Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $114.48B|Employees: 18K
Gilead Sciences is a biopharmaceutical company focused on developing and commercializing innovative medicines to treat life-threatening diseases, including HIV, viral hepatitis, and cancer. The company's primary revenue streams are from product sales, royalties, and collaborations, and it holds a significant market position due to its innovative medicines and strong R&D pipeline. Gilead operates in more than 35 countries worldwide.
Detailed Profile